FI  Savitr Capital

     Office Locations:

600 Montgomery Street, 47th Floor
San Francisco, CA 94111
Phone: 415-430-4200
Fax: 415-371-1840



  • Early
  • Growth



  • Energy & Clean Tech
  • Life Sciences & Healthcare
  • Manufacturing & Industrial
  • Medical Device



    Founded in 2008, Savitr Capital is a private investment firm managing assets for Andrew Midler, and focuses its direct capital investments in complex situations often involving the evolution, turnaround, or restructuring of a company. The firm focuses its own resources on a small number of investments at any one time. All capital is internal and permanent which provides for the flexibility to support the long term growth and maximization of value without the constraint of time. Savitr Capital is currently invested in a portfolio of innovation leaders focused in health care and industrial manufacturing. Mr. Midler currently serves on the board of directors of Druggability Technologies, Glytec Systems, CellMDX, Emerald Bio Agriculture, Ancora Heart, BioIQ, and Vascular Therapies. In the majority of these Savitr is a large shareholder and participates at the Board level. Previously, Mr. Midler founded Standard Pacific Capital in 1995. The investment management firm launched with $75M of assets and grew to over $5 billion.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Silicon Valley Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Andrew Reuben Midler Managing Member
    Farida Udaipurwala COO
    Ian Ferrier Advisor


    Portfolio companies include:

      Ancora Heart
        web link

        web link

        web link


    Recent News: